Cumberland Pharmaceuticals Inc. Operating Lease, Liability, Current
Cumberland Pharmaceuticals Inc. (CPIX) had Operating Lease, Liability, Current of $503.02 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability, Current $503.02K.
- 2026-03-31: Operating Lease, Liability, Current $485.16K.
- 2025-12-31: Operating Lease, Liability, Current $467.77K.
- 2025-09-30: Operating Lease, Liability, Current $401.44K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $503.02K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $485.16K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $467.77K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $401.44K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $386.08K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $371.09K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $356.51K 10-K · filed 2026-03-09 |
| 2024-09-30 | $391.69K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $376.78K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $362.24K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $348.09K 10-K · filed 2025-03-07 |
| 2023-09-30 | $334.29K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $320.84K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $158.37K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $172.91K 10-K · filed 2024-03-13 |
| 2022-09-30 | $229.60K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $512.32K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $766.49K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $969.68K 10-K · filed 2023-03-13 |
| 2021-09-30 | $1.09M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.07M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.04M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.02M 10-K · filed 2022-03-11 |
| 2020-09-30 | $991.97K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $967.66K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $943.81K 10-Q · filed 2020-05-22 |
| 2019-12-31 | $920.43K 10-K · filed 2021-03-12 |
| 2019-09-30 | $897.51K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $899.26K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.02M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |